Low MICA Gene Expression Confers an Increased Risk of Graves' Disease: A Mendelian Randomization Study

Area of Science:

• Immunology
• Genetics
• Endocrinology

Background:

• Natural killer group 2 member D (NKG2D) ligands (NKG2DLs) act as danger signals, promoting the removal of stressed cells by cytotoxic lymphocytes.
• NKG2DL expression is observed in peripheral immune cells like macrophages, but its functional impact remains unclear.

Purpose of the Study:

• To investigate the causal relationship between NKG2DL gene expression and various health risks.
• To explore the role of NKG2DLs, specifically MICA and MICB, in peripheral immune cells and their association with diseases.

Main Methods:

• Utilized expression-quantitative trait loci (eQTLs) from RNA-sequencing of peripheral blood mononuclear cells (PBMCs) to identify instrumental variables (IVs) for MICA and MICB.
• Employed Mendelian randomization and Phenome-Wide Association Studies (PheWAS) on a large Japanese cohort to assess causal effects on 58 health risks.

Main Results:

• Identified significant IVs for MICA and MICB gene expression.
• Established a causal effect of MICA expression on Graves' disease (GD), an autoimmune thyroiditis, with reduced odds of GD per standard deviation increase in MICA expression.
• Results were robust across sensitivity analyses, showing no significant pleiotropy.

Conclusions:

• Provides novel evidence linking NKG2DL expression, specifically MICA, to Graves' disease.
• Suggests an immunoregulatory function of MICA in PBMCs, highlighting its potential importance in inflammatory diseases.
• Recommends further functional studies to elucidate the mechanisms in inflammatory conditions.